arrow_back Back to App

Protecting Medical Innovation: Opposing Intellectual Property Waivers

This act aims to protect intellectual property rights in medical innovations, especially those related to COVID-19. It means the U.S. will not support proposals to waive these rights at the World Trade Organization, intending to ensure continued development of new medicines and vaccines. For citizens, this could mean faster access to innovative therapies, but also potentially higher prices for patented drugs.
Key points
Prohibits supporting the waiver of intellectual property rights for COVID-19 medicines and vaccines at the World Trade Organization.
Promotes strong international intellectual property rights to encourage medical innovation.
Protects American investments and medical technology from being taken by other countries.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_3035
Sponsor: Rep. Donalds, Byron [R-FL-19]
Process start date: 2021-05-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Preventing Foreign Attempts to Erode Healthcare Innovation Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3035.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-05-07.

What are the main provisions?

Key points include:

  • Prohibits supporting the waiver of intellectual property rights for COVID-19 medicines and vaccines at the World Trade Organization.
  • Promotes strong international intellectual property rights to encourage medical innovation.
  • Protects American investments and medical technology from being taken by other countries.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Donalds, Byron [R-FL-19].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Economy